A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

This study has been completed.

Study NCT00402077 Information provided by Amylin Pharmaceuticals, Inc.

First Received: November 17, 2006 Last Updated: January 8, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2007
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)